{"id":46541,"date":"2022-07-25T23:01:56","date_gmt":"2022-07-25T21:01:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/"},"modified":"2022-07-25T23:01:56","modified_gmt":"2022-07-25T21:01:56","slug":"ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/","title":{"rendered":"ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET"},"content":{"rendered":"
\n

BAUDETTE, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (\u201cANI\u201d or the \u201cCompany\u201d) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2022 financial results on Monday, August 8, 2022, prior to market open.\n<\/p>\n

<\/a><\/p>\n

\nNikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows:\n<\/p>\n\n\n\n\n\n
\n

\nDate\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\nMonday, August 8, 2022\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTime\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n8:00 a.m. ET\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nToll free (U.S.)\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n800-225-9448\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nWebcast (live and replay)\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\nwww.anipharmaceuticals.com<\/a>, under the \u201cInvestors\u201d section\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nA replay of the conference call will be available within two hours of the call\u2019s completion and will remain accessible for two weeks by dialing 800-753-6121 and entering access code 7163806.\n<\/p>\n

\nAbout ANI
\n
<\/b>ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is a diversified biopharmaceutical company serving patients by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin\u00ae<\/sup> Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations:<\/b>
Lisa M. Wilson, In-Site Communications, Inc.
\n
212-452-2793
\n
lwilson@insitecony.com<\/a><\/p>\n

Media:<\/b>
Faith Pomeroy-Ward, Director, Commercial Market Development, ANI Pharmaceuticals
\n
817-807-8044
\n
Faith.pomeroyward@anipharmaceuticals.com<\/a>
SOURCE: ANI Pharmaceuticals, Inc.<\/i>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BAUDETTE, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (\u201cANI\u201d or the \u201cCompany\u201d) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2022 financial results on Monday, August 8, 2022, prior to market open. Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46541","6":"format-standard","7":"category-industry"},"yoast_head":"\nANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BAUDETTE, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (\u201cANI\u201d or the \u201cCompany\u201d) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2022 financial results on Monday, August 8, 2022, prior to market open. Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-25T21:01:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220725005660\/en\/1306511\/21\/ANI_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET\",\"datePublished\":\"2022-07-25T21:01:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\\\/\"},\"wordCount\":246,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220725005660\\\/en\\\/1306511\\\/21\\\/ANI_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\\\/\",\"name\":\"ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220725005660\\\/en\\\/1306511\\\/21\\\/ANI_logo.jpg\",\"datePublished\":\"2022-07-25T21:01:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220725005660\\\/en\\\/1306511\\\/21\\\/ANI_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220725005660\\\/en\\\/1306511\\\/21\\\/ANI_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/","og_locale":"en_US","og_type":"article","og_title":"ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET - Pharma Trend","og_description":"BAUDETTE, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (\u201cANI\u201d or the \u201cCompany\u201d) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2022 financial results on Monday, August 8, 2022, prior to market open. Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-25T21:01:56+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220725005660\/en\/1306511\/21\/ANI_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET","datePublished":"2022-07-25T21:01:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/"},"wordCount":246,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220725005660\/en\/1306511\/21\/ANI_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/","url":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/","name":"ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220725005660\/en\/1306511\/21\/ANI_logo.jpg","datePublished":"2022-07-25T21:01:56+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220725005660\/en\/1306511\/21\/ANI_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220725005660\/en\/1306511\/21\/ANI_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ani-pharmaceuticals-to-discuss-second-quarter-2022-financial-results-on-august-8-2022-at-800-a-m-et\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46541","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46541"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46541\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46541"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46541"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46541"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}